These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 34862670)

  • 1. Investigating historic cases of pyoderma gangrenosum in myelodysplastic syndrome and chronic myelomonocytic leukemia for possible VEXAS syndrome: A systematic review.
    Croitoru DO; Huang RS; McMullen EP; Maazi M; Piguet V
    J Am Acad Dermatol; 2024 Oct; 91(4):712-714. PubMed ID: 38906261
    [No Abstract]   [Full Text] [Related]  

  • 2. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
    Lewerin C; Mobacken H; Nilsson-Ehle H; Swolin B
    Leuk Lymphoma; 1997 Aug; 26(5-6):629-32. PubMed ID: 9389372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of etoposide for pyoderma gangrenosum associated with myelodysplastic syndrome and trisomy 8: cytokine profiles during treatment.
    Fujiwara D; Hamada T; Yamasaki O; Sando Y; Saeki K; Fujii N; Kawakami Y; Iwatsuki K
    Eur J Dermatol; 2017 Oct; 27(5):525-527. PubMed ID: 28943508
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment with ustekinumab and vacuum-assisted closure therapy in recalcitrant myelodysplastic syndrome-associated pyoderma gangrenosum: case report and literature review.
    Nieto D; Sendagorta E; Rueda JM; Herranz P
    Clin Exp Dermatol; 2019 Jan; 44(1):116-119. PubMed ID: 29851121
    [No Abstract]   [Full Text] [Related]  

  • 5. Image Gallery: Pyoderma gangrenosum in a patient with myelodysplastic syndrome treated with azacitidine.
    Pardo Pastor J; Redondo Capafons S; March López P; Nicolás Picó J; Pineda A; Martí JM
    Br J Dermatol; 2017 Sep; 177(3):e68. PubMed ID: 28940271
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of pyoderma gangrenosum associated with myelodysplastic syndrome using high-dose intravenous immunoglobulin.
    Tamaki K; Nakazawa T; Mamehara A; Tsuji G; Saigo K; Kawano S; Morinobu A; Kumagai S
    Intern Med; 2008; 47(23):2077-81. PubMed ID: 19043265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome.
    Korekawa A; Nakajima K; Nakano H; Sawamura D
    J Dermatol; 2022 Apr; 49(4):e131-e132. PubMed ID: 34862670
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyoderma gangrenosum affecting the eye, orbit, and adnexa. A review.
    McElnea E; Stephenson K; Fulcher T
    Orbit; 2018 Feb; 37(1):26-31. PubMed ID: 28862478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
    García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
    Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum: an inflammatory ulcer.
    Samuel J; Williams C
    J Wound Care; 1996 Jul; 5(7):314-8. PubMed ID: 8954419
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyoderma gangrenosum: an Indian perspective.
    Bhat RM; Nandakishore B; Sequeira FF; Sukumar D; Kamath GH; Martis J; Furtado S
    Clin Exp Dermatol; 2011 Apr; 36(3):242-7. PubMed ID: 21070329
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.